Tanne D - Search Results

1

Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial.

Tanne D, Levine SR, Brey RL, Lin H, Tilley BC; NINDS rt-PA Stroke Study Group. Tanne D, et al. Neurology. 2003 Oct 28;61(8):1158-9. doi: 10.1212/01.wnl.0000086809.46485.a1. Neurology. 2003. PMID: 14581697 Clinical Trial. No abstract available.

2

Antiphospholipid-protein antibodies and ischemic stroke: not just cardiolipin any more.

Tanne D, Triplett DA, Levine SR. Tanne D, et al. Stroke. 1998 Sep;29(9):1755-8. doi: 10.1161/01.str.29.9.1755. Stroke. 1998. PMID: 9731590 No abstract available.

3

Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases.

D'Olhaberriague L, Levine SR, Salowich-Palm L, Tanne D, Sawaya KL, Aurora TK, Perry M, Day M, Spencer T, Schultz L. D'Olhaberriague L, et al. Among authors: tanne d. Neurology. 1998 Nov;51(5):1376-80. doi: 10.1212/wnl.51.5.1376. Neurology. 1998. PMID: 9818863

4

Anticardiolipin antibodies and their associations with cerebrovascular risk factors.

Tanne D, D'Olhaberriague L, Schultz LR, Salowich-Palm L, Sawaya KL, Levine SR. Tanne D, et al. Among authors: d olhaberriague l. Neurology. 1999 Apr 22;52(7):1368-73. doi: 10.1212/wnl.52.7.1368. Neurology. 1999. PMID: 10227619

5

Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group.

Tanne D, Bates VE, Verro P, Kasner SE, Binder JR, Patel SC, Mansbach HH, Daley S, Schultz LR, Karanjia PN, Scott P, Dayno JM, Vereczkey-Porter K, Benesch C, Book D, Coplin WM, Dulli D, Levine SR. Tanne D, et al. Neurology. 1999 Jul 22;53(2):424-7. doi: 10.1212/wnl.53.2.424. Neurology. 1999. PMID: 10430444 Clinical Trial.

6

Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.

Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Tilley BC, Brott TG, Haley EC Jr, Lyden PD, Kothari R, Frankel M, Lewandowski CA, Libman R, Kwiatkowski T, Broderick JP, Marler JR, Corrigan J, Huff S, Mitsias P, Talati S, Tanne D. Grotta JC, et al. Among authors: tanne d. Stroke. 1999 Aug;30(8):1528-33. doi: 10.1161/01.str.30.8.1528. Stroke. 1999. PMID: 10436095 Clinical Trial.

7

Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience.

Tanne D, Gorman MJ, Bates VE, Kasner SE, Scott P, Verro P, Binder JR, Dayno JM, Schultz LR, Levine SR. Tanne D, et al. Stroke. 2000 Feb;31(2):370-5. doi: 10.1161/01.str.31.2.370. Stroke. 2000. PMID: 10657408

8

Predictors of good outcome after intravenous tPA for acute ischemic stroke.

Demchuk AM, Tanne D, Hill MD, Kasner SE, Hanson S, Grond M, Levine SR; mMulticentre tPA Stroke Survey Group. Demchuk AM, et al. Among authors: tanne d. Neurology. 2001 Aug 14;57(3):474-80. doi: 10.1212/wnl.57.3.474. Neurology. 2001. PMID: 11502916

9

Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study.

Tanne D, D'Olhaberriague L, Trivedi AM, Salowich-Palm L, Schultz LR, Levine SR. Tanne D, et al. Among authors: d olhaberriague l. Neuroepidemiology. 2002 Mar-Apr;21(2):93-9. doi: 10.1159/000048623. Neuroepidemiology. 2002. PMID: 11901279

10

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.

Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR. Tanne D, et al. Circulation. 2002 Apr 9;105(14):1679-85. doi: 10.1161/01.cir.0000012747.53592.6a. Circulation. 2002. PMID: 11940547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page